Palatin Technologies Inc. (PTN)

[seasonedwell]

Palatin Technologies, Inc. (PTN) Stock Rating Reaffirmed by Roth Capital
September 27th, 2016 - By Doug Wharley - 0 comments

Palatin Technologies (NYSE:PTN)‘s stock had its “buy” rating restated by Roth Capital in a research note issued to investors on Friday. They presently have a $4.00 price objective on the biopharmaceutical company’s stock.

A number of other equities analysts have also weighed in on the company. Zacks Investment Research upgraded Palatin Technologies from a “hold” rating to a “buy” rating and set a $0.75 price target for the company in a research report on Friday. S&P Equity Research reduced their price objective on Palatin Technologies from $0.61 to $0.55 in a research note on Thursday, September 22nd. Finally, Canaccord Genuity set a $6.00 price objective on Palatin Technologies and gave the stock a “buy” rating in a research note on Tuesday, September 20th.

Palatin Technologies (NYSE:PTN) opened at 0.619 on Friday. Palatin Technologies has a 12-month low of $0.36 and a 12-month high of $0.90. The firm has a 50-day moving average price of $0.54 and a 200-day moving average price of $0.53. The stock’s market cap is $53.19 million.